Carigent Therapeutics Inc.
|
|
|
|
|
platform allows for controlled release of therapeutic agents tethering of surface ligands; targeting of therapy to a particular physiological site and the ability to combine multiple agents into one vehicle made primarily from FDA-approved materials | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|